Policy Spotlight: One-on-One Conversation with Michelle McMurry-Heath, President and CEO, Biotechnology Innovation Organization (BIO)

Date: Friday, November 12, 2021
Time: 1:00 p.m. – 2:00 p.m. Eastern / 10:00 a.m. – 11:00 a.m. Pacific

You are invited to join Health Affairs Editor-in-Chief Alan Weil when he welcomes Michelle McMurry-Heath, President and CEO the Biotechnology Innovation Organization (BIO), for a discussion of current topics in pharmaceuticals including, but not limited to, reducing barriers to vaccines and other life-saving technologies, and policy relating to generics, patents, and prices.

A medical doctor and molecular immunologist by training, Dr. McMurry-Heath previously held leadership roles at Johnson & Johnson (J&J), was associate science director of the FDA’s Center for Devices and Radiological Health, and was the founding director of the Aspen Institute’s Health, Biomedical Science, and Society Policy Program. Broadening access to scientific progress so more patients from diverse backgrounds can benefit from cutting-edge innovation has been a common thread across her work.

Please email your questions in advance to [email protected] and we will make every effort, in the limited time available, to have them addressed. First priority will be given to topics relevant to the widest swath of the audience.

Journal Club: "Estimating The Appropriate Size Of Global Pull Incentives For Antibacterial Medicines" by Kevin Outterson, Boston University School of Law

Date: Wednesday, November 10, 2021
Time: 3:00 p.m. – 4:00 p.m. Eastern / 12:00 p.m. – 1:00 p.m. Pacific

The centerpiece of the November Health Affairs Journal Club meeting is "Estimating The Appropriate Size Of Global Pull Incentives For Antibacterial Medicines." In the paper, to appear in the November 2021 issue of the journal, author Kevin Outterson of the Boston University School of Law, examines policy initiatives under way in the US and UK that explore paying for exceptional antibacterials with "pull" incentives (paid after regulatory approval). The paper lays out a new model for calculating the global incentives required to create a functional antibacterial market, and on November 10, Mr. Outterson will talk in detail about his research, methods, and conclusions.

About Health Affairs

Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.

Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States

Privacy Policy

To unsubscribe from this email, click here.